Reliably Assessing Duration of Protection for COVID-19 Vaccines
Dan-Yu Lin, Donglin Zeng, Yu Gu, Thomas R Fleming, Philip R Krause
doi: https://doi.org/10.1101/2021.12.22.21268201
Dan-Yu Lin
1University of North Carolina at Chapel Hill
Ph.DDonglin Zeng
1University of North Carolina at Chapel Hill
Ph.D.Yu Gu
1University of North Carolina at Chapel Hill
B.S.Thomas R Fleming
2University of Washington
Ph.D.Philip R Krause
3US Food and Drug Administration
M.D.Data Availability
There are no actual data in this manuscript
Posted December 27, 2021.
Reliably Assessing Duration of Protection for COVID-19 Vaccines
Dan-Yu Lin, Donglin Zeng, Yu Gu, Thomas R Fleming, Philip R Krause
medRxiv 2021.12.22.21268201; doi: https://doi.org/10.1101/2021.12.22.21268201
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (195)
- Cardiovascular Medicine (2873)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12596)
- Forensic Medicine (10)
- Gastroenterology (809)
- Genetic and Genomic Medicine (4470)
- Geriatric Medicine (405)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1054)
- Hematology (378)
- HIV/AIDS (905)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4225)
- Nursing (226)
- Nutrition (619)
- Oncology (2215)
- Ophthalmology (628)
- Orthopedics (255)
- Otolaryngology (321)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1179)
- Primary Care Research (485)
- Public and Global Health (6810)
- Radiology and Imaging (1499)
- Respiratory Medicine (904)
- Rheumatology (430)
- Sports Medicine (371)
- Surgery (474)
- Toxicology (59)
- Transplantation (204)
- Urology (175)